Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D007112:Immunity, Maternally-Acquired; D007114:Immunization; D007116:Immunization, Passive; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000276:immunology; D051379:Mice; D009368:Neoplasm Transplantation; D016038:Skin Transplantation; D013451:Sulfonic Acids / Q000627:therapeutic use; D014181:Transplantation Immunology; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D013451:Sulfonic Acids; D003561:Cytarabine